These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30026826)

  • 1. Stromal Infiltration of Tumor-Associated Macrophages Conferring Poor Prognosis of Patients with Basal-Like Breast Carcinoma.
    Yang M; Li Z; Ren M; Li S; Zhang L; Zhang X; Liu F
    J Cancer; 2018; 9(13):2308-2316. PubMed ID: 30026826
    [No Abstract]   [Full Text] [Related]  

  • 2. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer.
    Jeong H; Hwang I; Kang SH; Shin HC; Kwon SY
    J Breast Cancer; 2019 Mar; 22(1):38-51. PubMed ID: 30941232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast.
    Jamiyan T; Kuroda H; Yamaguchi R; Abe A; Hayashi M
    Virchows Arch; 2020 Dec; 477(6):767-775. PubMed ID: 32607685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated CD163
    Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
    Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
    Mwafy SE; El-Guindy DM
    J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature.
    Zhao X; Qu J; Sun Y; Wang J; Liu X; Wang F; Zhang H; Wang W; Ma X; Gao X; Zhang S
    Oncotarget; 2017 May; 8(18):30576-30586. PubMed ID: 28427165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
    Bisheshar SK; van der Kamp MF; de Ruiter EJ; Ruiter LN; van der Vegt B; Breimer GE; Willems SM
    Oral Oncol; 2022 Dec; 135():106227. PubMed ID: 36335818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma.
    Kim KJ; Wen XY; Yang HK; Kim WH; Kang GH
    PLoS One; 2015; 10(12):e0144192. PubMed ID: 26714314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of CD68
    Troiano G; Caponio VCA; Adipietro I; Tepedino M; Santoro R; Laino L; Lo Russo L; Cirillo N; Lo Muzio L
    Oral Oncol; 2019 Jun; 93():66-75. PubMed ID: 31109698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
    Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
    Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages in Oral Carcinomas: Relationship with Cancer Stem Cell Markers and PD-L1 Expression.
    Suárez-Sánchez FJ; Lequerica-Fernández P; Suárez-Canto J; Rodrigo JP; Rodriguez-Santamarta T; Domínguez-Iglesias F; García-Pedrero JM; de Vicente JC
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis.
    Allison E; Edirimanne S; Matthews J; Fuller SJ
    Oncol Ther; 2023 Mar; 11(1):27-48. PubMed ID: 36484945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Associated CD163
    Guo F; Feng YC; Zhao G; Zhang R; Cheng ZZ; Kong WN; Wu HL; Xu B; Lv X; Ma XM
    Cancer Manag Res; 2020; 12():5831-5843. PubMed ID: 32765086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
    Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
    Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of CD68, CD163 and Folate receptor-β positive macrophages in hepatocellular carcinoma.
    Minami K; Hiwatashi K; Ueno S; Sakoda M; Iino S; Okumura H; Hashiguchi M; Kawasaki Y; Kurahara H; Mataki Y; Maemura K; Shinchi H; Natsugoe S
    Exp Ther Med; 2018 May; 15(5):4465-4476. PubMed ID: 29731831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the infiltration of CD163
    Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J
    Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.
    Sugimura K; Miyata H; Tanaka K; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    J Surg Oncol; 2015 May; 111(6):752-9. PubMed ID: 25752960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.